X BODY INC
- Headquarters
- WALTHAM, MA
- Founded
- 2008
- Latest Form D
- $2.7M, Apr 2015
- Total capital
- $2.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.7M
- 1 Form D · last Apr 2015
- 139 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 15
- 14 pending · first 2016
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Richard W. WagnerResearcherExecutive Officer, DirectorLinked by 3 patents
- Brant W. BinderExecutive Officer, DirectorNamed in SEC Form D filings
- Gordon W. BinderDirectorNamed in SEC Form D filings
- Jeffrey W. TrodermanExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 15 granted of 29- GrantedBi-specific Antigen-binding PolypeptidesUSPTOUS 11,814,441
- GrantedAntibody Screening MethodsUSPTOUS 11,629,434
- PendingTarget Antigen Discovery, Phenotypic Screens And Use Thereof For Identification Of Target Cell Specific Target EpitopesUSPTOApplication 17816017
Show all 29 patent records
- Bi-specific Antigen-binding PolypeptidesNov 14, 2023 · US 11,814,441Granted
- Antibody Screening MethodsApr 18, 2023 · US 11,629,434Granted
- Target Antigen Discovery, Phenotypic Screens And Use Thereof For Identification Of Target Cell Specific Target EpitopesMar 9, 2023 · Application 17816017Pending
- Target Antigen Discovery, Phenotypic Screens And Use Thereof For Identification Of Target Cell Specific Target EpitopesAug 16, 2022 · US 11,414,784Granted
- Methods And Compositions For Generation Of Binding Agents Against Cell Surface AntigensMay 24, 2022 · US 11,339,388Granted
- Pdgf Receptor Beta Binding PolypeptidesMar 24, 2022 · Application 17410324Pending
- X-display Complexes For Protein Screening MethodsMar 8, 2022 · US 11,268,090Granted
- Pdgf Receptor Beta Binding PolypeptidesOct 5, 2021 · US 11,136,398Granted
- Methods for Identifying Modulators of Ion ChannelsMay 25, 2021 · US 11,016,100Granted
- Antibody Screening MethodsJun 9, 2020 · US 10,677,787Granted
- Antigen Receptor Screening AssayJun 4, 2020 · Application 16676103Pending
- Pdgf Receptor Beta Binding PolypeptidesMar 31, 2020 · US 10,604,578Granted
- Protein Screening MethodsDec 31, 2019 · US 10,519,438Granted
- Methods And Compositions For Generation Of Binding Agents Against Cell Surface AntigensDec 31, 2019 · US 10,519,436Granted
- Target Antigen Discovery, Phenotypic Screens And Use Thereof For Identification Of Target Cell Specific Target EpitopesAug 6, 2019 · US 10,370,651Granted
- Bi-specific Antigen-binding PolypeptidesFeb 12, 2019 · US 10,202,462Granted
- Protein Screening MethodsOct 31, 2017 · US 9,803,193Granted
- Antigen Receptor Screening AssayAug 18, 2016 · Application 15025670Pending
- Pdgf Receptor Beta Binding PolypeptidesAug 16, 2016 · US 9,416,179Granted
- Methods of Detection of Changes in CellsMar 28, 2013 · Application 13663553Pending
- Pdgf Receptor Beta Binding PolypeptidesApplication PCTUS2012067909Pending
- Clonal Derivation And Cell Culture Quality Control Screening MethodsApplication PCTUS2012061905Pending
- Antibody Screening MethodsApplication PCTUS2012029086Pending
- Use Of Induced Pluripotent Cells And Other Cells For Screening Compound LibrariesApplication PCTUS2011030198Pending
- Identification Of Nucleic Acid Delivery Vehicles Using Dna DisplayApplication PCTUS2010024296Pending
- Bi-specific Antigen-binding PolypeptidesApplication PCTUS2015021668Pending
- Antigen Receptor Screening AssayApplication PCTUS2014057672Pending
- Methods And Compositions For Generation Of Binding Agents Against Cell Surface AntigensApplication PCTUS2014056782Pending
- Target Antigen Discovery, Phenotypic Screens And Use Thereof For Identification Of Target Cell Specific Target EpitopesApplication PCTUS2014043454Pending
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .